Skip to main content

A disruptive technology for treating coronary artery disease.

new-graphic2-banner

Who We Are

Advanced Bifurcation Systems®

ABS is a coronary medical device company based in the San Francisco Bay area with a fully developed FDA Class III medical device specifically designed to treat all indications of bifurcation disease. With over 95 issued U.S. and international patents, as well as the coveted FDA Breakthrough Device Designation, ABS is positioned to be the industry’s standard of care. Our platform is specifically designed with coronary left main arteries in mind, and is adaptable to address challenges in the endovascular and neurovascular sectors.

Advanced Bifurcation Benefits

Introducing a paradigm shift in interventional cardiology that benefits all parties

Patients

Better outcomes and a reduction in need for open-heart surgery.

Physicians

Our technology allows all interventionalists—not just the experts—to confidently perform the procedure, expanding access to advanced care for more patients.

Hospitals

Optimize utilization and boost revenue from bifurcation procedures by reducing procedure times, enabling more efficient patient flow and increased throughput.

Insurers

Leverage a significant reduction in material costs and further savings from shorter procedure times, driving significant cost-efficiency for insurance providers

Advanced Bifurcation Systems® platform in action

Transforming bifurcation stenting: precision, simplicity, and better outcomes.

ABS MD-BI
ABS Side-branch Access Stenting System (ABS MD-SBA)
ABS MD-BI
ABS Two Stent System (ABS MD-BI)